[HTML][HTML] Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission

JA Gregory, F Li, LM Tomosada, CJ Cox, AB Topol… - PloS one, 2012 - journals.plos.org
Subunit vaccines are significantly more expensive to produce than traditional vaccines
because they are based primarily on recombinant proteins that must be purified from the …

Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that …

KP Patra, F Li, D Carter, JA Gregory, S Baga… - Infection and …, 2015 - Am Soc Microbiol
ABSTRACT A vaccine to prevent the transmission of malaria parasites from infected humans
to mosquitoes is an important component for the elimination of malaria in the 21st century …

Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii

CS Jones, T Luong, M Hannon, M Tran… - Applied microbiology …, 2013 - Springer
Malaria is a widespread and infectious disease that is a leading cause of death in many
parts of the world. Eradication of malaria has been a major world health goal for decades …

Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines

JA Gregory, AB Topol, DZ Doerner… - Applied and …, 2013 - Am Soc Microbiol
Infectious diseases disproportionately affect indigent regions and are the greatest cause of
childhood mortality in developing countries. Practical, low-cost vaccines for use in these …

Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25

J Kubler-Kielb, F Majadly, Y Wu… - Proceedings of the …, 2007 - National Acad Sciences
Malaria is a leading cause of morbidity and mortality, estimated to cause> 1 million
childhood deaths annually. Plasmodium falciparum causes the most severe form of the …

[HTML][HTML] Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission

GE Canepa, A Molina-Cruz, L Yenkoidiok-Douti… - NPJ vaccines, 2018 - nature.com
Transmission-blocking vaccines are based on eliciting antibody responses in the vertebrate
host that disrupt parasite development in the mosquito vector and prevent malaria …

[HTML][HTML] Identification of domains within Pfs230 that elicit transmission blocking antibody responses

M Tachibana, K Miura, E Takashima, M Morita… - Vaccine, 2019 - Elsevier
A transmission-blocking vaccine (TBV) against Plasmodium falciparum is likely to be a
valuable tool in a malaria eradication program. Pfs230 is one of the major TBV candidates …

Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity

CE Farrance, JA Chichester, K Musiychuk… - Human …, 2011 - Taylor & Francis
Malaria is a serious and sometimes fatal mosquito-borne disease caused by a protozoan
parasite. Each year, it is estimated that over one million people are killed by malaria, yet the …

[HTML][HTML] Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

SM Lee, CK Wu, J Plieskatt, DH McAdams, K Miura… - Malaria journal, 2016 - Springer
Abstract Background Transmission-blocking vaccines (TBVs) have become a focus of
strategies to control and eventually eliminate malaria as they target the entry of sexual stage …

A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum

CE Farrance, A Rhee, RM Jones… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
Plasmodium falciparum is transmitted to a new host after completing its sexual cycle within a
mosquito. Developing vaccines against the parasite sexual stages is a critical component in …